Reported Mar 1, 2023 · Terminated

TIROSINT - SOL (levothyroxine sodium) Oral Solution, 88 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for…

Ibsa Pharma Inc.

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: IBSA PHARMA INC · 8 Campus Dr Ste 201 · Parsippany, NJ · 07054-4409

Is this the product you have?

TIROSINT - SOL (levothyroxine sodium) Oral Solution, 88 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for IBSA Pharma Inc. by

3 of 3 products

Products covered by this recall
#Product as published
1IBSA Institut Biochimique SA, 6912 Pazzallo, Switzerland
2Distributed by: IBSA Pharma Inc., Parsippany, NJ 07054
3NDC 71858-0125-5
Lot codes and dates
    • Lot #: 220411
    • Exp. 10/2023
    • 220854
    • Exp. 02/2024
Amount recalled
N/A

This recall covers 15 products

The agency filed one notice per product. You are reading one of them; the other 14 are below.

2 more are in the archive.

Where it was sold

  • Nationwide

Why it was recalled

Subpotent Drug

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Ibsa Pharma Inc. recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Notice updated Oct 31, 2023 · Data as of Sep 19, 8:02 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.